Accessible Complexity

Chiromics aims to take drug discovery to the next level by generating vast chemical libraries that contain Accessible Complexity. The development of Chiromics proprietary chemical sequences has enabled the synthesis of stereo-defined small molecule collections. These accessibly complex screening decks are designed to engage biological targets with broad applications toward drug design for human diseases.


Chiromics has developed a first-in-class positive allosteric modulators of the μ-opioid receptor for the treatment of pain. This non-opiate based pain therapeutic program holds promise to address the nations opioid overdose crisis.


Chiromics has partnered with over 15 large and small pharmaceutical companies to accelerate drug Discovery programs. We can divulge the following alliances:


Website by Princeton Internet Group, Inc. (PING)